Although CXCR2 inhibition was shown to reduce neutrophil recruitment to tumor in mice15–21 and in in vitro models of human lung cancer and breast cancer24,25, it is unknown whether CXCR2 inhibition could also reduce neutrophil recruitment to human pancreatic tumor tissue. The gene discussed is CXCR2; the disease is neoplasm.